The Herpes Simplex Virus (HSV) is a virus that affects humans and is a major cause of genital herpes. It is a member of the Herpesviridae family and is divided into two types, HSV-1 and HSV-2. HSV-1 is the most common cause of oral herpes, while HSV-2 is the most common cause of genital herpes. In the biotechnology market, HSV is a major focus of research and development. Companies are working to develop treatments and vaccines to prevent and treat HSV infections. These treatments and vaccines are designed to target the virus itself, as well as the symptoms associated with HSV infections. Additionally, research is being conducted to develop diagnostic tests to detect HSV infections. Companies in the HSV market include Gilead Sciences, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
